HHS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Harte Hanks Inc (HHS) is not a strong buy at the moment given the investor's beginner level, long-term strategy, and available capital. The lack of positive financial performance, no significant trading trends, and absence of strong proprietary trading signals suggest that holding off on this stock is a more prudent decision.
The MACD is positive and expanding, indicating slight bullish momentum, but the RSI is neutral at 43.728. The moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading near its pivot level of 2.377. Overall, the technical indicators do not strongly support a buy decision.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Financial performance in Q4 2025 shows significant declines across key metrics: revenue (-15.43% YoY), net income (-190.47% YoY), EPS (-190.91% YoY), and gross margin (-9.82%). No recent news or trading activity to offset these negatives.
In Q4 2025, Harte Hanks Inc reported a sharp decline in revenue, net income, EPS, and gross margin, reflecting poor financial health and lack of growth.
No analyst rating or price target data available.
